We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-1 of 1

New route for cooperation between the E.U. and the U.S. on biosimilars

  • Dechert LLP
  • -
  • European Union, USA
  • -
  • June 28 2011

The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have set up a new “cluster” on biosimilar medicines